Moderna starts human trials for Bundibugyo Ebola vaccine as Congo's outbreak continues

Summary

Moderna has vaccinated the first participants in a trial for a Bundibugyo Ebola vaccine, as the Democratic Republic of Congo continues to battle its fastest-growing outbreak on record.